View Older Stories View More Recent Stories
-
Craig-Hallum Starts Rank One Computing (ROC) at Buy
-
Aurora Innovation (AUR) Reiterated at Overweight by Cantor Fitzgerald on First-Mover Advantage
-
Verastem (VSTM) Reiterated at Overweight by Cantor Fitzgerald as Key Readout is Near
-
H.C. Wainwright Reiterates Buy Rating on Benitec BioPharma (BNTC)
-
Ocugen, Inc. (OCGN) PT Raised to $10 at H.C. Wainwright
-
Jefferies Upgrades dormakaba Holding AG (DOKA:SW) to Buy
-
Psyence BioMed unit signs ibogaine license term sheet with PsyLabs
-
GXO names Dan Davis president of new aerospace & defense role
-
GXO names Dan Davis president of new aerospace & defense role
-
Bruker unveils new proteomics workflows at HUPO 2026
-
ACI Worldwide and Cognizant test card processing software on AWS
-
Gates Foundation extends funding for AN2 and GSK tuberculosis research
-
BrewDog names four senior leaders across marketing and global ops
-
Metatek reports project progress in Japan and Azerbaijan
-
Eldorado Gold connects Skouries mine to Greek national power grid
-
naia Relief partners with Alumni-Perks to offer well-being platform to alumni
-
Rodman & Renshaw Starts Agenus Inc. (AGEN) at Buy
-
VisionWave details STRATUM unmanned ground platform family in development
-
Virtu Financial launches block trading for Saudi Exchange equities
-
Moleculin publishes cardiac safety analysis of Annamycin in five trials
-
NextSource secures $30M investment from Japan's Hanwa and JOGMEC
-
Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
-
Goldgroup Mining commits $75M investment in Luca Mining
-
Sirios Resources plans share consolidation and name change
-
Rezolute (RZLT) PT Raised to $10 at H.C. Wainwright
-
DA Davidson Downgrades Pegasystems (PEGA) to Neutral, 'Lower Conviction Near Term'
-
Global IP Thought Leaders, Scholars, and Policymakers to Gather in Paris for "Competing for the Cure" Conference on Biopharmaceutical Ecosystems
-
BluMetric Announces Extension of Mine Water Remediation Contract for 2027 Season
-
Gladiator Intersects 24.0m @ 2.37% Cu Including 13.1m @ 3.89% Cu from 8m at Cowley, Extending High-Grade Copper Mineralization to Surface
-
NextSource Materials Secures Binding Agreement for US$30 Million Strategic Investment from Japan's Hanwa and JOGMEC to Advance its UAE Battery Anode Facility
-
Eastport Reports 110.8m at 0.43% Cu at Nak-Main and Launches 291 km2 Gravity Survey at 30km Thole-Copper Snake Copper in Soil Anomaly
-
Irving Advances the Unoya Target at Its Shika Epithermal Au-Ag Project, Noto Peninsula, Honshu, Japan through Systematic Geological, Geochemical and Geophysical Work
-
Origen Advances Picos Rare Earth Project with Airborne Survey and Ground Exploration
-
Sirios Resources Announces Share Consolidation and Name Change
-
Zodiac Gold Identifies New Critical Mineral and Gold Anomalies Across Liberian Northwest Licenses
-
Grid Metals to Participate in Upcoming Investor Conferences
-
Temas 2026 Annual General & Special Meeting Voting Results
-
Fermi Selects NAES to Operate and Maintain Its Natural Gas Turbine Fleet
-
Metatek Provides Operational Update Regarding Projects Completing in Japan and Azerbaijan
-
TaxBandits Opens Q3 Form 941 and Certain State Form Filings Early Following Bulk Entry Launch
-
NSJ Antimony Corp. (NSJ) (9PZ) Announces Management Change and Issues Stock Options
-
naia Relief Inc. Announces Strategic Partnership with Alumni-Perks to Expand Access to 24/7 Well-Being Support for Canadian University/College Alumni
-
Goldgroup Announces Commitment for Strategic Investment in Luca Mining
-
Clear Blue Technologies Announces 1,000 Pico-Plus Unit Orders from Eutelsat for Deployment Across Africa
-
Zoe Financial Extends Fractional Share Trading to Schwab Accounts
-
Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives
-
H.C. Wainwright Reiterates Buy Rating on Regenxbio Inc. (RGNX)
-
Wells Fargo Upgrades Sweetgreen Inc (SG) to Overweight, 'we see upside ahead'
-
H.C. Wainwright Reiterates Buy Rating on Sagimet Biosciences Inc (SGMT)
-
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
